| Identification | Back Directory | [Name]
10-O-Vanilloylaucubin | [CAS]
193969-08-3 | [Synonyms]
10-O-Vanilloylaucubin
β-D-Glucopyranoside, (1S,4aR,5S,7aS)-1,4a,5,7a-tetrahydro-5-hydroxy-7-[[(4-hydroxy-3-methoxybenzoyl)oxy]methyl]cyclopenta[c]pyran-1-yl
[(1S,4~{a}R,5S,7~{a}S)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4~{a},5,7~{a}-tetrahydrocyclopenta[c]pyran-7-yl]methyl 4-hydroxy-3-methoxybenzoate | [Molecular Formula]
C23H28O12 | [MDL Number]
MFCD20260587 | [MOL File]
193969-08-3.mol | [Molecular Weight]
496.46 |
| Hazard Information | Back Directory | [Description]
10-O-Vanilloylaucubin shows significant writhing inhibition following oral administration at doses of 25 mg/kg.suggests that it has analgesic effects. |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|